Physician profile

Vivian Letran

Surgery · Dublin, CA

NPI 1184981029

$3,871.82

in general payments reported to CMS, 2019-2025

43 companies · $656 in 2025

The $656 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).

See the full distribution for Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,807.14

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Vector Surgical, LLC $461.03 2019-2025
Davol INC. $373.98 2020-2025 Phasix Mesh
Takeda Pharmaceuticals U.S.A., INC. $275.06 2019-2025 Iclusig, Ninlaro, Fruzaqla
Focal Therapeutics, INC. $231.55 2019
Merck Sharp & Dohme LLC $215.16 2019-2023 Keytruda, Lynparza
Myriad Genetic Laboratories, INC. $182.77 2023-2024 Myrisk
Ethicon US, LLC $181.85 2019-2023 Dermabond Prineo
Lilly USA, LLC $155.62 2019-2025 Verzenio, Jaypirca, Retevmo
Amgen INC. $142.66 2020-2022
Molli Surgical (US) INC $133.79 2023
Intuitive Surgical, INC. $118.83 2023-2024 Da Vinci Surgical System
Acera Surgical, INC. $111.11 2024 Restrata Wound Matrix
Astrazeneca Pharmaceuticals LP $108.86 2022-2025 Imfinzi
Hologic Sales and Service, LLC $108.37 2025 Sentimag
Avanos Medical $105.34 2022-2025 On-Q* Pump and Accessories, On-Q Pump and Accessories
Show all 43 companies
CompanyGeneral paymentsYearsTop products
Endomagnetics LTD $67.43 2022
Acell, INC. $58.82 2019
Bioptics, INC. $53.30 2022
Janssen Biotech, INC. $48.61 2019-2023 Darzalex
Puma Biotechnology, INC. $47.52 2020-2021
Boehringer Ingelheim Pharmaceuticals, INC. $46.93 2019-2021
Stryker Corporation $45.24 2023-2025 Molli, Spy-Phi System
Incyte Corporation $44.70 2020-2025 Monjuvi
Rigel Pharmaceuticals, INC. $40.37 2019-2022
Eisai INC. $38.61 2019-2025
Novartis Pharmaceuticals Corporation $34.76 2025
Genzyme Corporation $31.82 2023
Sumitomo Pharma America, INC. $31.18 2023 Orgovyx
Tela Bio, INC. $30.78 2020
Emd Serono, INC. $30.71 2023-2024 Tepmetko
Stemline Therapeutics INC. $30.24 2025 Orserdu
Siemens Medical Solutions USA, INC. $29.41 2023 Varian Cryocare Touch System
Myovant Sciences INC. $28.88 2022
Aveo Pharmaceuticals, INC. $26.32 2024
Exelixis INC. $26.18 2019
Elucent Medical $24.73 2025
Beigene USA, INC. $23.84 2023 Brukinsa
Covidien LP $22.76 2020
Tempus Ai, INC $22.41 2025 Xt Cdx
Regeneron Healthcare Solutions, INC. $22.09 2022
Bayer Healthcare Pharmaceuticals INC. $21.91 2019
Deciphera Pharmaceuticals INC. $18.77 2023 Qinlock
Adc Therapeutics America, INC. $17.52 2025

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Vivian Letran

$3,871.82

in general payments reported 2019-2025

Years
2019-2025
Top company
Vector Surgical, LLC
Context
The $656 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).

https://glasscript.com/doctor/5511290/vivian-letran

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Download CSV

The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.